Potential precipitating factors of esophageal variceal bleeding: A case-control study

American Journal of Gastroenterology

Volumn 106, Issue 1, 2011, Pages 96-103

  Liao, Wei Chih ^a,b   Hou, Ming Chih ^a,b   Chang, Chen Jung ^b   Lee, Fa Yauh ^a,b   Lin, Han Chieh ^a,b   Lee, Shou Dong ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; CONSTIPATION; CONTROLLED STUDY; COUGHING; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; VALSALVA MANEUVER; VOMITING;

AGE DISTRIBUTION; AGED; ALCOHOL DRINKING; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; CONSTIPATION; COUGH; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOSCOPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRECIPITATING FACTORS; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TAIWAN; VOMITING;

EID: 78650981116     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.342     Document Type: Article

References (41)

1. North-Italian Endoscopic Club for the study and treatment of esophageal varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988; 319: 983-9.
2. D'Amico G, Pagliaro L, Bosch J. Pharmacologic treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999; 19: 475-505.
3. Bernard B, Lebrec D, Mathurin P et al. Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a metaanalysis. J Hepatol 1997; 26: 312-24.
4. Khuroo MS, Khuroo NS, Farahat KL et al. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 2005; 21: 347-61.
5. Staritz M, Poralla T, Meyer zum B ü schenfelde KH. Intravascular oesophageal variceal pressure (IOVP) assessed by endoscopic fine needle puncture under basal conditions, Valsalva's manoeuvre and after glyceryltrinitrate application. Gut 1985; 26: 525-30.
6. Escorsell A, Gin è s A, Llach J et al. Increasing intra-abdominal pressure increases pressure, volume, and wall tension in esophageal varices. Hepatology 2002; 36: 936-40.
7. Luca A, Cirera I, Garc í a-Pag á n JC et al. Hemodynamic Effects of acute changes in intra-abdominal pressure in patients with cirrhosis. Gastroenterology 1993; 104: 222-7.
8. Kravetz D, Romero G, Argonz J et al. Total volume paracentesis decreases variceal pressure, size, and variceal wall tension in cirrhotic patients. Hepatology 1997; 25: 59-62.
9. Luca A, Feu F, García-Pagán JC et al. Favorable Effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites. Hepatology 1994; 20: 30-3.
10. Bandi JC, García-Pagán JC, Escorsell A et al. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology 1998; 28: 677-82.
11. García-Pagàn JC, Santos C, Barberá JA. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology 1996; 111: 1300-6.
12. Luca A, García-Pagán JC, Bosch J et al. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 1997; 112: 1284-9.
13. De Lédinghen V, Heresbach D, Fourdan O et al. Anti-inflammatory drugs and variceal bleeding: a case-control study. Gut 1999; 44: 270-3.
14. De Lédinghen V, Mannant PR, Foucher J et al. Non-steroidal anti-in- flammatory drugs and variceal bleeding: a case-control study. J Hepatol 1996; 24: 570-3.
15. Drossman DA, Corazziari E, Talley NJ et al. ROME II: The Functional Gastrointestinal Disorders. 2nd edn. Lawrence: Allen Press, Inc., 2000.
16. Berg DT. New chemotherapy treatment options and implications for nursing care. Oncol Nurs Forum 1997; 24 (Suppl 1): 5-12.
17. Allen CJ, Anvari M. Gastro-oesophageal reflux related cough and its response to laparoscopic fundoplication. Thorax 1998; 53: 963-8.
18. McCormick PA, Morgan MY, Phillips A et al. The Effects of alcohol use on rebleeding and mortality in patients with alcoholic cirrhosis following variceal haemorrhage. J Hepatol 1992; 14: 99-103.
19. Beppu K, Inokuchi K, Koyanagi N et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981; 27: 213-8.
20. Pugh RN, Murray-Lyon IM, Dawson JL et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
21. Hou MC, Lin HC, Liu TT et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 2004; 39: 746-53.
22. Sung JJ, Yeo W, Suen R et al. Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate. Gastrointest Endosc 1998; 47: 235-9.
23. Chen WC, Hou MC, Lin HC et al. Feasibility and potential benefit of maintenance endoscopic variceal ligation in patients with unresectable hepatocellular carcinoma and acute esophageal variceal hemorrhage: a controlled trial. Gastrointest Endosc 2001; 54: 18-23.
24. Bambha K, Kim WR, Pedersen R et al. Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut 2008; 57: 814-20.
25. Wong ML, Wee S, Pin CH et al. Sociodemographic and lifestyle factors associated with constipation in an elderly Asian community. Am J Gastroenterol 1999; 94: 1283-91.
26. Lu CL, Chang FY, Chen CY et al. Significance of Rome II-defined functional constipation in Taiwan and comparison with constipation-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2006; 24: 429-38.
27. Cheng C, Chan AO, Hui WM et al. Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation: a population- based study. Aliment Pharmacol Ther 2003; 18: 319-26.
28. Miele VJ, Bendok B, Bloomfield SM et al. Ventriculoperitoneal shunt dysfunction in adults secondary to conditions causing a transient increase in intra-abdominal pressure: report of three cases. Neurosurgery 2004; 55: 434.
29. Mart í nez-Lage JF, Martos-Tello JM, Ros-de-San Pedro J et al., Constipation: an under-appreciated cause of VP shunt malfunction: a case-based update. Childs Nerv Syst, 2008, 24, 431-5.
30. Iqbal A, Haider M, Stadlhuber RJ et al. A study of intragastric and intravesicular pressure changes during rest, coughing, weight lift ing, retching, and vomiting. Surg Endosc 2008; 22: 2571-5.
31. Addington WR, Stephens RE, Phelipa MM et al. Intra-abdominal pressures during voluntary and reflex cough. Cough 2008; 4: 2.
32. Ready JB, Hossack KF, Rector WG Jr. The Effects of ethanol administration on portal pressure and gastroesophageal collateral blood flow in patients with alcoholic cirrhosis. Hepatology 1990; 11: 674-7.
33. Powell WJ Jr, Klatskin G. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible Effects of recent changes in general management of the disease. Am J Med 1968; 44: 406-20.
34. Dagradi AE. The natural history of esophageal varices in patients with alcoholic liver cirrhosis. An endoscopic and clinical study. Am J Gastroenterol 1972; 57: 520-40.
35. Soterakis J, Resnick RH, Iber FL. Effect of alcohol abstinence on survival in cirrhotic portal hypertension. Lancet 1973; ii: 65-7.
36. Pande NV, Resnick RH, Yee W et al. Cirrhotic portal hypertension: morbidity of continued alcoholism. Gastroenterology 1978; 74: 64-9.
37. Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet 1988; 2: 1267-73.
38. Clària J, Kent JD, López-Parra M et al. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites. Hepatology 2005; 41: 579-87.
39. Wilcox CM, Shalek KA, Cotsonis G. Striking prevalence of over-thecounter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage. Arch Intern Med 1994; 154: 42-6.
40. Goulis J, Patch D, Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 1999; 353: 139-42.
41. Kadouchi K, Higuchi K, Shiba M et al. What are the risk factors for aggravation of esophageal varices in patients with hepatocellular carcinoma? J Gastroenterol Hepatol 2007; 22: 240-6.